EU GMP Annex Updates 2026: N-Nitrosamines, ATMP GMP, and EMA’s Evolving Inspection Landscape All Category, GMP Compliance, Insights, Regulatory / development / March 11, 2026 EU GMP Annex Updates 2026: N-Nitrosamines, ATMP GMP, and EMA’s Evolving Inspection Landscape Read More »
FDA & EMA’s Joint Guiding Principles for Good AI Practice in Drug Development All Category, Blogs, Clinical Regulatory, regulatory / development / March 10, 2026 FDA & EMA’s Joint Guiding Principles for Good AI Practice in Drug Development Read More »
FDA QMSR Is Now in Effect: What the New Inspection Regime Means for Medical Device Manufacturers All Category, Blogs, GMP Compliance, Medical Device, regulatory / development / March 10, 2026 FDA QMSR Is Now in Effect: What the New Inspection Regime Means for Medical Device Manufacturers Read More »
Drug Safety Just Got Smarter: Inside the EMA’s 2026 GVP Updates Overhaul All Category, Blogs, Pharmacovigilance / development / March 2, 2026 Drug Safety Just Got Smarter: Inside the EMA’s 2026 GVP Updates Overhaul Read More »
Brazil-India Health Pact: What the New Drug Approvals and Regulatory Agreement Mean for Patients All Category, Clinical Regulatory, Insights, Regulatory / development / February 25, 2026 Brazil-India Health Pact: What the New Drug Approvals and Regulatory Agreement Mean for Patients Read More »
Risk Management Plans: Structure, Maintenance, and Regulatory Triggers for Updates All Category, Blogs, Pharmacovigilance / development / February 24, 2026 Risk Management Plans: Structure, Maintenance, and Regulatory Triggers for Updates Read More »
Regulatory Impact of Manufacturing Site Transfers All Category, Blogs, GMP Compliance, regulatory / development / February 20, 2026 Regulatory Impact of Manufacturing Site Transfers Read More »
Artwork Development for Multi-Country African Markets Submissions All Category, Case Studies, Publishing, Regulatory / development / February 26, 2026 Artwork Development for Multi-Country African Markets Submissions Read More »
UDI Requirements Across US, EU, and Other Emerging Markets All Category, Blogs, Medical Device, regulatory / development / February 18, 2026 UDI Requirements Across US, EU, and Other Emerging Markets Read More »
Clinical and Non-Clinical Data Gap Analysis for EU and UK Submissions All Category, Case Studies, Clinical Regulatory, Regulatory / development / February 26, 2026 Clinical and Non-Clinical Data Gap Analysis for EU and UK Submissions Read More »
